Mayo Clinic methotrexate monitoring trial, rheumatic diseases

Mayo Clinic registered an observational study (NCT07512401) on ClinicalTrials.gov examining methotrexate monitoring protocols for patients with rheumatic diseases. The trial will enroll patients taking methotrexate for conditions including rheumatoid arthritis, psoriatic arthritis, and other inflammatory disorders to evaluate current monitoring practices and their effectiveness.

Healthcare providers participating in or referring patients to this study should ensure proper informed consent procedures. Clinical investigators must comply with applicable federal clinical trial registration and results reporting requirements under FDAAA 801. Patients and advocacy groups may monitor the trial's progress through ClinicalTrials.gov.